drugset / Trial / NCT01843127
A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
RandomizedCrossoverSingle-blindTreatment
Summary
To explore the mechanism of action of ranolazine as a potential treatment for type 2 diabetes mellitus (T2DM).
Timeline
- Start
- 2013-04
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Exenatide | Peptide | — | — |
| Comparator | Ranolazine | Small molecule | — | — |